We Accelerate Discovery

You are here

Printer

LINCS OUTREACH PRESENTATIONS

  1. Cellarium Project Technology presentation at ASU’s Night of the Open Door, March 2013
     
  2. ceRNA regulatory interactions cooperate with genomic variability to modulate drivers of tumorigenesis. Cold Spring Harbor Labs Meeting on Systems Biology Networks, Cold Spring Harbor, NY, March 13-14, 2013.
     
  3. X. Zhou, Systems Biology Approach for Cancer Research, Wake Forest University School of Medicine, Brian Tumor Center of Excellence, March, 2013, invited talk
     
  4. “High-throughput Profiling of Single Cell Secretomic Signatures”, invited talk, PITTCON 2013 Conference, Symposium – Microfluidics Approaches to Quantitative Biology and Medicine (Pittsburgh, March 2013)
     
  5. Cellarium Project Technology presentation at the National Human Genome Advisory Council Meeting, February 2013
     
  6. A systems biology approach to the elucidation of drivers of tumor initiation, progression, and chemosensitivity. Children's Hospital of Philadelphia's Oncology Seminar, Philadelphia, PA, February 19, 2013.
     
  7. Schürer, S.; “BioAssay Ontology (BAO) and the LINCS Information FramEwork (LIFE) to integrate and analyze diverse high throughput and cellular profiling assay data”, presented at CHI Molecular Medicine Triconference, San Francisco, Feb 11-15 2013
     
  8. A Systems Biology Approach to Elucidating Master Regulators of Tumor Initiation, Progression, and Chemosensitivity. Memorial Sloan Kettering Cancer Center Cancer Biology and Genetics Seminar, New York, NY February 8, 2013
     
  9. What does it take to practice systems biology and why it is relevant to cancer research. AACR –NBTS Cancer Systems Biology Think Tank Philadelphia, PA, January 16, 2013.
     
  10. Schürer, S.; “BioAssay Ontology” presented at the Academic Drug Discovery Special Interest Group at the 2nd Annual Conference of the Society for Laboratory Automation and Screening Biomolecular Sciences, Orlando, Jan 12-16, 2013
     
  11. X. Zhou, L1000 data analysis and genomics data analysis, Wake Forest University School of Medicine, Genomics Center, Jan, 2013, invited talk
     
  12. “Revisit the Central Dogma at the Genome Scale and in Single Cells”, department seminar series, Departmentof Biomedical Engineering, Yale University (New Haven, CT, January 2013)
     
  13. Organizer of The Fifth Annual RECOMB Conference on Regulatory and Systems Genomics, with DREAM Challenges. Redwood City, CA November 12-15, 2012.
     
  14. A systems view of the cancer cell: from missing genetic variability to combination therapy. NCRI Cancer Conference, Liverpool ,UK November 4-7, 2012.
     
  15. “Single Cell Microtechnology for Systems Oncobiology”, invited talk, 2012 PS-OC Symposium – Understanding Cancer: Genomes to Devices (New York City, November, 2012)
     
  16. Cellarium Project Technology presentation at the Tenth Annual Grantee Meeting of CEGS, October 2012
     
  17. Discovering oncogene and non-oncogene dependencies in human malignancies. Seminars in Oncology Dana Farber Institute Boston, MA, October 23. 2012.
     
  18. Leveraging oncogene and non-oncogene addiction in selecting therapeutic agents on an individual patient basis. 2012 CTEP Fall 2012 Early Drug Development Meeting NIH Bethesda, MD, October 15-16, 2012
     
  19. Discovering oncogene and non-oncogene dependencies in human malignancies. Dana Farber Cancer Institute Physical Science-Oncology Center/National Cancer Institute. Boston, MA October, 13, 2012.
     
  20. X. Zhou, Discussions on Precision Medicine 2012 NIH-MSM, NIH campus, Oct, 2012
     
  21. “Single-cell analysis of HIV-1 Nef-induced inflammatory responses in human macrophages”, Biomedical Engineering Society Annual Meeting (Atlanta, GA, October 2012).
     
  22. “Single Cell BioMEMS for Systems Oncology”, invited talk, EITA Bio Conference, Princeton University (Princeton NJ, October 2012).
     
  23. “Single-cell Microfluidics for Systems OncoBiology”, invited talk, High-throughput Biology, Cold Spring Harbor Meetings - Asia (Suzhou, China, October 2012).
     
  24. microRNA mediates interactions explain a large fraction of the missing genetic variability in cancer. Third International Symposium on Cancer, microRNAs, and other non-coding RNAs. University College London, London September 11-13, 2012
     
  25. X. Zhou, Workshop on Omics Data Integration, Wake Forest University School of Medicine, Aug, 2012
     
  26. Interrogating Regulatory Networks to discover master regulators of tumor initiation, progression, and drug sensitivity. Regulatory Events for Lung Cell Carcinoma, Vanderbilt University Nashville, TN July 12, 2012.
     
  27. Interrogating Regulatory Networks to Discover Master Regulators of Tumor Initiation, Progression and Drug Sensitivity. Roche Symposium in Systems Biology on Applications of Systems Biology to Drug Discovery & Development. Nutley, NJ June 11-12, 2012
     
  28. “Nanowire Arrays for Rare Cell Analysis”, invited talk, 7th US-Sino Nano Forum (Xiamen, China, June 2012).
     
  29. X. Zhou, Bioinformatics and LINCS, 2012 Tongji University, Shanghai, China, May, 2012, invited talk
     
  30. “Single cell microfluidics for systems oncology”, invited talk, the 3th International Conference on Advances in Microfluidics and Nanofluidics (Dalian, China, May 2012).
     
  31. “Single cell microtechnology for systems oncology”, invited talk, 28th Southern Biomedical Engineering Conference (Houston, TX, May 2012).
     
  32. X. Zhou, Computational Systems Biology, 2012 George State University, Atlanta, GA, April, 2012, invited talk
     
  33. “Single cell microfluidics for systems immunology”, invited seminar speaker, New York Medical College (Westchester County, NY, April 2012).
     
  34. “Single cell microfluidics for systems oncology”, invited, NCI’s Third Physical Sciences – Oncology Center Consortium Annual Meeting (Tampa, FL, April 2012).
     
  35. Presentation as part of the Biomarker course at Brigham and Women’s Hospital, March 2012
     
  36. A Systems Biology approach to elucidate oncogene addiction in high grade glioma. Weill Cornell Medical College, Ney York, NY, March 26, 2012.
     
  37. Yale: “Single cell microfluidics to assess cancer heterogeneity” invited, the American Physical Society (APS) Meeting (Boston, MA, March 2012).
     
  38. “Single cell microfluidics for systems oncology” invited, the American Chemical Society (APS) Meeting (San Diego, CA, March 2012).
     
  39. Schürer, S.; “BioAssay Ontology Facilitates Standardization, Integration and Meta-Analysis of Massive High-Throughput Screening (HTS) Datasets”, presented at CHI Molecular Medicine Triconference, San Francisco, Feb 19-22 2012
     
  40. Interrogating Regulatory Networks to Elucidate Non-oncogense Addiction in Cancer. MD Anderson, Houston TX, February 15-16, 2012.
     
  41. Schürer, S.; “BioAssay Ontology Facilitates Standardization, Integration and Meta-Analysis of Massive High-Throughput Screening (HTS) Datasets”, presented at the SIG Data and Image Analysis at the 1st Annual Conference of the Society for Laboratory Automation and Screening (SLAS), San Diego, Feb 8, 2012
     
  42. “Single cell microtechnology and systems medicine” invited, Department of Mechanical Engineering, University of Michigan (UMich, Ann Arbor, MI, Feb 2012).
     
  43. Assembling and interrogating cancer cell regulatory networks to identify master regulators of human malignancies. Dana Farber Cancer Institute Physical Science-Oncology Center/National Cancer Institute. Boston, MA January 19, 2012
     
  44. Assembling and interrogating regulatory interaction networks to elucidate mechanisms of cancer initiation, progression, and drug sensitivity. Broad Cancer Program Meeting, Cambridge, MA November 14-15, 2011.

SCHEDULED

  1. “Single-cell Molecular Profiling to Assess Cancer Heterogeneity”, invited talk, AAPS annual meeting, San Diego (to be given in May 2013).
     
  2. “Single-cell Microtechnology for Systems Oncology”, invited talk/Cancer Nanotechnology Seminar, Stanford University (to be given in April 2013).
     
Up to Top